Joseph F. Goldberg, MD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Corresponding Author: Joseph F. Goldberg, MD, 128 East Ave, Norwalk, CT 06851 ([email protected]).

JCP
Valproate and Weight Gain: A New Look at an Old Problem
Commentary

March 27, 2024

Dr Goldberg comments on a recent cohort study demonstrating a dose relationship with weight gain liability for valproate.
Joseph F. Goldberg
JCP
Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders?
ASCP Corner

January 31, 2024

This article provides a practical overview of the evidence supporting lamotrigine’s efficacy and identifies shortcomings of previous study designs.
Joseph F. Goldberg
JCP
Lurasidone and Anxiety Symptoms in Bipolar Depression
Original Research

June 7, 2023

Lurasidone was superior to placebo at reducing anxiety in bipolar depression. Change in anxiety symptoms was predicted by sleep disturbance at baseline.
Joseph F. Goldberg, Cynthia Siu, Michael Tocco, et al
JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
Joseph F. Goldberg
JCP
Addressing Unmet Needs in Bipolar Disorder
Academic Highlights

November 16, 2022

Bipolar disorder presents on a spectrum, with bipolar depression on one end and bipolar I on the other and a host of other presentations in between. As guidelines are...
Joseph F. Goldberg, Melissa P. DelBello, Holly A. Swartz
JCP
Living in a Pharmacologically Imperfect World
Editorial

October 12, 2022

Joseph F. Goldberg, MD, comments on prescription of valproate in women of reproductive potential, and the risk-benefit analysis involved with choosing the least imperfect treatment option.
Joseph F. Goldberg
JCP
Recognizing Bipolar Disorder in Pregnant and Postpartum Women
Editorial

July 13, 2022

In this editorial, Drs Freeman and Goldberg comment on a meta-analysis by Masters and colleagues on the prevalence of bipolar disorder in perinatal women.
Marlene P. Freeman, Joseph F. Goldberg
JCP
Recognizing Impaired Decisional Capacity in Vaccine Refusal: Reply to Kels and Kels
Letter to the Editor

February 1, 2022

The authors reply to a letter commenting on Dr Goldberg’s JCP editorial examining COVID-19 vaccine hesitancy.
Joseph F. Goldberg, Jacob M. Appel
JCP
Commentary

January 4, 2022

This commentary discusses the review by Vaccarino and colleagues of cognitive effects associated with ketamine treatment for major depressive disorder.
Joseph F. Goldberg
JCP
Academic Highlights

October 12, 2021

Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
Robert L. Findling, Joseph F. Goldberg
JCP
Editorial

August 24, 2021

This editorial from JCP Section Editor Joseph F. Goldberg explores the psychological underpinnings of anti-vaccine attitudes and calls on psychiatrists to help combat this threat to public health.
Joseph F. Goldberg
JCP
Brief Report

August 17, 2021

This study examined childhood trauma and current traumatic stress ratings in bipolar and unipolar inpatients to see if higher levels of childhood trauma and current trauma symptoms are associated...
Amir Garakani, Frank D. Buono, Kaitlyn Larkin, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe